Hill, Mitch C.'s Form 4 filing
Inari Medical, Inc. (NARI) · filed May 18, 2022
- Accession no.
- 0001127602-22-014970
- Filed
- May 18, 2022, 4:40 PM ET
- Trade date
- May 16, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $443.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hill, Mitch C.CIK 0001644989 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2022 | Common Stock | MOption exerciseAcquired | +7,500 | $0.457 | +$3,427.5 | 87,062 | Direct | |
| May 16, 2022 | Common Stock | SSaleDisposed | −1,505 | $56.86F2 | −$85,574.3 | 85,557 | Direct | |
| May 16, 2022 | Common Stock | SSaleDisposed | −1,304 | $57.87F3 | −$75,462.48 | 84,253 | Direct | |
| May 16, 2022 | Common Stock | SSaleDisposed | −1,100 | $59.28F4 | −$65,208 | 83,153 | Direct | |
| May 16, 2022 | Common Stock | SSaleDisposed | −2,232 | $60.18F4 | −$134,321.76 | 80,921 | Direct | |
| May 16, 2022 | Common Stock | SSaleDisposed | −1,359 | $61.05F5 | −$82,966.95 | 79,562 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2022 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 214,477 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $56.41 to $57.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $57.43 to $58.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $59.66 to $60.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 2 transactions in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $60.66 to $61.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.